Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis

Oncotarget

Volumn 5, Issue 11, 2014, Pages 3472-3481

  Lee, Hyun Sung ^a,b   Lee, Kwanbok ^c   Jang, Hee Jin ^a   Lee, Geon Kook ^b   Park, Jong Lyul ^d,e   Kim, Seon Young ^d,e   Kim, Sang Bae ^a   Johnson, Betty H ^c   Zo, Jae Ill ^f   Lee, Ju Seog ^a,g   Lee, Yong Sun ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b National Cancer Center   (South Korea)

^c University of Texas Medical Branch School of Medicine   (United States)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e University of Science and Technology (UST)   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g Kyung Hee University Hospital   (South Korea)

Author keywords

CpG DNA methylation; ESCC; nc886; Tumor suppressor

Indexed keywords

NC886; RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER CELL LINE; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FOS GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROARRAY ANALYSIS; NF KB GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE MYC; PROMOTER REGION; PYROSEQUENCING; RECURRENCE FREE SURVIVAL; RNA ISOLATION; BIOSYNTHESIS; ESOPHAGUS TUMOR; GENETIC EPIGENESIS; GENETICS; MOLECULAR GENETICS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENES; RNA, UNTRANSLATED;

EID: 84903530355     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1927     Document Type: Article

References (26)

1. Kunkeaw N, Jeon SH, Lee K, Johnson BH, Tanasanvimon S, Javle M, Pairojkul C, Chamgramol Y, Wongfieng W, Gong B, Leelayuwat C and Lee YS. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene. 2013; 32(32):3722-3731.
2. Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, Bang JY, Park HS, Leelayuwat C and Lee YS. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA. 2011; 17(6):1076-1089.
3. Cao J, Song Y, Bi N, Shen J, Liu W, Fan J, Sun G, Tong T, He J, Shi Y, Zhang X, Lu N, He Y, Zhang H, Ma K, Luo X, et al. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res. 2013; 73(11):3326-3335.
4. Treppendahl MB, Qiu X, Sogaard A, Yang X, Nandrup-Bus C, Hother C, Andersen MK, Kjeldsen L, Mollgard L, Hellstrom-Lindberg E, Jendholm J, Porse BT, Jones PA, Liang G and Gronbaek K. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood. 2012; 119(1):206-216.
5. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM and Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986; 4(3):325-345.
6. Fairman J, Chumakov I, Chinault AC, Nowell PC and Nagarajan L. Physical mapping of the minimal region of loss in 5q-chromosome. Proc Natl Acad Sci U S A. 1995; 92(16):7406-7410.
7. Garcia MA, Meurs EF and Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie. 2007; 89(6-7):799-811.
8. Jeon SH, Lee K, Lee KS, Kunkeaw N, Johnson BH, Holthauzen LM, Gong B, Leelayuwat C and Lee YS. Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett. 2012; 586(19):3477-3484.
9. Lau LF and Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci U S A. 1987; 84(5):1182-1186.
10. Amstad P, Crawford D, Muehlematter D, Zbinden I, Larsson R and Cerutti P. Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. Bull Cancer. 1990; 77(5):501-502.
11. Zullo JN, Cochran BH, Huang AS and Stiles CD. Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell. 1985; 43(3 Pt 2):793-800.
12. DiDonato JA, Mercurio F and Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012; 246(1):379-400.
13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12):2893-2917.
14. Mariette C, Finzi L, Piessen G, Van Seuningen I and Triboulet JP. Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg. 2005; 29(1):39-45.
15. Takai D and Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A. 2002; 99(6):3740-3745.
16. Ransone LJ and Verma IM. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol. 1990; 6:539-557.
17. Cole MD. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet. 1986; 20:361-384.
18. Eychene A, Rocques N and Pouponnot C. A new MAFia in cancer. Nat Rev Cancer. 2008; 8(9):683-693.
19. Lasorella A, Uo T and Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene. 2001; 20(58):8326-8333.
20. Zinn K, Keller A, Whittemore LA and Maniatis T. 2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science. 1988; 240(4849):210-213.
21. Filipowicz W, Bhattacharyya SN and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102-114.
22. Wilusz JE, Sunwoo H and Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009; 23(13):1494-1504.
23. Coussens LM and Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860-867.
24. Romano P, Manniello A, Aresu O, Armento M, Cesaro M and Parodi B. Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines. Nucleic Acids Res. 2009; 37(Database issue):D925-932.
25. Kim SY and Volsky DJ. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics. 2005; 6:144.
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-15550.